Number of the records: 1  

TRAIL/APO2L inhibits myelodysplasia and myeloid leukemia progenitor growth while it does not affect normal progenitors in vitro and normal CD3+ cell repopulation in NOD/SCID mice

  1. 1.
    0191427 - UMG-J 20010499 RIV US eng J - Journal Article
    Plašilová, M. - Živný, J. - Jelínek, J. - Neuwirtová, R. - Čermák, J. - Nečas, E. - Anděra, Ladislav - Stopka, T.
    TRAIL/APO2L inhibits myelodysplasia and myeloid leukemia progenitor growth while it does not affect normal progenitors in vitro and normal CD3+ cell repopulation in NOD/SCID mice.
    Blood. Roč. 98, č. 11 (2001), s. 3043. ISSN 0006-4971. E-ISSN 1528-0020
    R&D Projects: GA AV ČR IAA5052001
    Institutional research plan: CEZ:AV0Z5052915
    Keywords : TRAIL * leukemia * apoptosis
    Subject RIV: EB - Genetics ; Molecular Biology
    Impact factor: 9.273, year: 2001

    normal hematopoieticĺ progenitors and stem cells.#Lemfeld
    Permanent Link: http://hdl.handle.net/11104/0087180

     
     

Number of the records: 1